Next Article in Journal
2-[2,6-Diisopropylphenyl]-4-phenyl-5H-5,9b[1′,2′]-benzonaphtho[1,2-b]pyrrol-2-ium Tetrafluoroborate
Previous Article in Journal
Synthesis, Characterization and Chemistry of Tetrakis(Propargylisocyanide) Copper(I) Complex
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

(Z)-5-Benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole

Department of Pharmacy, Showa Pharmaceutical University, Machida 194-8543, Tokyo, Japan
*
Authors to whom correspondence should be addressed.
Molbank 2023, 2023(1), M1600; https://doi.org/10.3390/M1600
Submission received: 8 February 2023 / Revised: 21 February 2023 / Accepted: 24 February 2023 / Published: 6 March 2023
(This article belongs to the Topic Catalysis: Homogeneous and Heterogeneous)

Abstract

:
By strategic use of the valence difference between hard gold(III) and soft gold(I) catalysts, one-pot synthesis of (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole (15) from propargylic alcohol (9) and p-toluamide (13) was achieved via gold(III)-catalyzed propargylic substitution followed by gold(I)-catalyzed cyclization. The structure of 15 was confirmed by X-ray crystallographic analysis.

1. Introduction

Oxazoline and oxazole are frequently found as structural constituents of natural products and biologically active compounds [1,2] and are also useful as reagents and intermediates in organic synthesis [3,4,5]. Therefore, many synthetic methods have been developed, most of which are based on cyclization to oxazolines 4 or cycloisomerization to oxazoles 5 from propargylic amides 3 in the presence of transition metals [6,7] or other reagents [8,9] (Scheme 1). On the other hand, there are no reports of oxazoline 4 synthesis and only a few reports [10,11,12] of oxazole 5 synthesis by propargylic substitution-cyclization/cycloisomerization sequences from propargylic alcohol 1 and amide 2, making this sequential transformation a challenging task because both propargylic substitution and subsequent cyclization/cycloisomerizarion should proceed effectively (Scheme 1).
So far, oxazoles 5 have been synthesized via propargylic substitution/cycloisomerization from propargylic alcohols 1 and amides 2 by using a combination of two transition metals (Cp*RuCl(μ2-SMe)2RuCp*Cl/AuCl3/NH4BF4 [10]) or (Zn(OTf)2/TpRuPPh3(CH3CN)2PF6 [11]). However, these methods are applicable only to terminal propargylic alcohols 1 (R1 = H), affording oxazoles 5 (R1 = H) with a methyl group at the 5-position. Zhan et al. reported a one-pot synthesis of oxazoles 5 from propargylic alcohols 1 and amides 2 in the presence of p-toluenesulfonic acid monohydrate (PTSA) [12]. Although this procedure has a wide scope for the preparation of oxazoles 5 and is superior to the former two methods in that it requires only a single kind of catalyst, a stoichiometric amount of PTSA is required in the reaction. Thus, the development of an efficient procedure for the construction of oxazoline 4 and oxazole 5 from propargylic alcohol 1 and amide 2 is still required.
We have developed an efficient synthesis of heterocyclic compounds (cyclic ethers [13]/piperidines [14]/azepanes [15]) from propargylic alcohols by strategic use of oxophilic (hard) gold(III) and π-philic (soft) gold(I) catalysts. We also extended this procedure to the gold-catalyzed intermolecular reaction of propargylic alcohols with carbon nucleophiles, affording cyclic compounds (indenes [16]/dihydropyrans [17]). In addition, we developed a gold-catalyzed synthesis of substituted oxazoles 8 from 3-trimethylsilylpropargylic alcohols 6 and amides 2 via propargylic substitution followed by cycloisomerization in one pot [18] (Scheme 2). Activation of the triple bond by the gold catalyst and the β-cation-stabilizing effect (7-Au) of the silicon atom in the propargylic amide 7 are both important for the cycloisomerization process.
We also found that the propargylic substitution reaction proceeds to give propargylic amide 10 as an intermediate when the silyl group at the terminal position of alkyne in propargylic alcohol is changed to a phenyl group, but the cyclization/cycloisomerization process to furnish oxazoline 11/oxazole 12 from propargylic amide 10 does not proceed. To overcome this problem, we planned to dramatically accelerate the cyclization/cycloisomerization from propargylic amide 10 through the activation of the triple bond (10-Au) by a soft gold(I) catalyst [19] (Scheme 3). Here, we present a one-pot synthesis of (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole (15) from propargylic alcohol 9 and p-toluamide (13) via a gold(III)-catalyzed propargylic substitution followed by gold(I)-catalyzed cyclization.

2. Results and Discussion

2.1. Chemistry

The reaction conditions in the first propargylic substitution reaction of propargylic alcohol 9 and p-toluamide (13) were those identified in our previous work (5 mol% AuBr3/15 mol% AgOTf in toluene, reflux, 20 min). For the cyclization of propargylic amide 14, we investigated the soft gold(I) catalyst Ph3PAuNTf2 (Scheme 4). Finally, treatment of propargylic alcohol 9 with p-toluamide (13) in the presence of AuBr3 (5 mol%) and AgOTf (15 mol%) in toluene at reflux for 20 min afforded propargylic amide 14, and then addition of Ph3PAuNTf2 (5 mol%) and MS 4A resulted in cyclization to furnish oxazoline 15 in 52% yield in one pot. The NMR spectroscopic data supported the formation of oxazoline 15, and the expected structure was confirmed by means of X-ray crystallographic analysis [20].

2.2. X-ray Structure Analysis

X-Ray analysis for a single crystal of oxazoline 15 grown via slow diffusion of dichloromethane solvent at room temperature revealed a triclinic crystal structure and a P-1 space group (Table 1, Figure 1A, the Supplementary Material). The torsional angle between the p-tolyl ring and the oxazoline ring is 0.30o and that between the oxazoline ring and the phenyl ring is 0.01o, indicating that these three rings are nearly co-planar. The crystal packing was driven by the combination of the intermolecular π−π stacking interaction (3.4 Å) (Figure 1, (B) green line) between the tolyl group and two intermolecular CH-π interactions (2.8 Å) (Figure 1, (B) yellow line) between the methyl group and sp2–carbon of the carbon–carbon double bond.

3. Materials and Methods

3.1. General Information

1H and 13C NMR spectra were recorded with a BRUKER AV-300 spectrometer (Bruker, Billerica, MA, USA) at room temperature, with tetramethylsilane as an internal standard (CDCl3 solution). Chemical shifts were recorded in ppm, and coupling constants (J) in Hz. Infrared (IR) spectra were recorded with a Shimadzu IRSpirit-T. Mass spectra (Shimadzu, Kyoto, Japan) were recorded on JEOL JMS-700 spectrometers (JEOL, Tokyo, Japan). Merck silica gel 60 (1.09385) and Merck silica gel 60 F254 were used for column chromatography and thin layer chromatography (TLC), respectively.

3.2. Synthesis of (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole (15)

AuBr3 (5.3 mg, 0.012 mmol, 5 mol%) and AgOTf (9.4 mg, 0.036 mmol, 15 mol%) were added at room temperature to a solution of 1,3-diphenylprop-2-yn-1-ol (9) (50 mg, 0.24 mmol) and p-toluamide (13) (33 mg, 0.24 mmol) in toluene (4 mL), and the mixture was heated at reflux for 20 min. After confirming consumption of the starting alcohol 9 and the production of propargylic amide 14, Ph3PAuNTf2 (19 mg, 0.012 mmol, 5 mol%) and MS 4A (100 mg) were added at room temperature. The reaction mixture was stirred at 60 oC for 24 h, then filtered, and the filtrate was concentrated in vacuo. The crude product was subjected to column chromatography on silica gel (hexane:AcOEt = 20:1) to give the oxazoline 15 (41 mg, 52%).
Mp. 152-153 oC; IR (ATR) 3085, 3061, 3028, 2921, 1695, 1647, 1611, 1493, 1452, 1278, 1179, 1059, 1019 cm-1; 1H-NMR (300 MHz, CDCl3) δ 8.05 (2H, d, J = 8.4 Hz), 7.59 (2H, d, J =8.4 Hz), 7.40-7.29 (9H, m), 7.25-7.18 (1H, m), 5.93 (1H, d, J = 2.4 Hz), 5.52 (1H, d, J = 2.4 Hz), 2.45 (3H, s); 13C-NMR (75 MHz, CDCl3) δ 163.0, 155.5, 142.8, 140.4, 134.8, 129.4, 128.9, 128.5, 128.4, 128.1, 128.0, 127.6, 126.3, 123.6, 102.8, 74.1, 21.7; HRMS (EI) m/z calcd for C23H19NO 325.1467, found 325.1473. The supporting 1H-NMR, 13C-NMR, IR and mass spectra are presented in the Supplementary Material Files.

4. Conclusions

By the strategic use of the valence difference between hard gold(III) and soft gold(I) catalysts, we were able to synthesize (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole (15) by gold(III)-catalyzed propargylic substitution, followed by gold(I)-catalyzed cyclization in one pot. We are currently examining the application of this method to the synthesis of various (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole derivatives.

Supplementary Materials

The following materials are available online. Figure S1. 1H, 13C-NMR, IR, HRMS and X-ray data (CCDC-2239857) of (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole (15).

Author Contributions

Conceptualization, N.M.; experiments; H.C. and S.A.; X-ray analysis, N.M.; writing—original draft preparation, N.M.; writing—review and editing, K.T.III, Y.H. and O.T.; supervision, N.M.; project administration, N.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the JSPS KAKENHI (grant number 20 K05517).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Yeh, V.S.C. Recent advances in the total synthesis of oxazole-containing natural products. Tetrahedron 2004, 60, 11995–12042. [Google Scholar]
  2. Wipf, P. Synthetic studies of biologically active marine cyclopeptides. Chem. Rev. 1995, 95, 2115–2134. [Google Scholar] [CrossRef]
  3. Lipshulz, B.H. Five-membered heteroatomic rings as intermediates in organic synthesis. Chem. Rev. 1986, 86, 795–819. [Google Scholar] [CrossRef]
  4. Wipf, P.; Venkatraman, S. From aziridines to oxazolines and thiazolines: The heterocyclic route to thiangazole. Synlett 1997, 1997, 1–10. [Google Scholar] [CrossRef]
  5. Dong, K.; Gurung, R.; Xu, X.; Doyle, M.P. Enantioselective catalytic cyclopropanation-rearrangement approach to chiral spiroketals. Org. Lett. 2021, 23, 3955–3959. [Google Scholar] [CrossRef] [PubMed]
  6. Bresciani, S.; Tomkinson, N.C.O. Transition metal-mediated synthesis of oxazoles. Heterocycles 2014, 89, 2479–2542. [Google Scholar]
  7. Senadi, G.C.; Hu, W.-P.; Hsiao, J.-S.; Vandavasi, J.K.; Chen, C.-Y.; Wang, J.-J. Facile, selective, and regiocontrolled synthesis of oxazolines and oxazoles mediated by ZnI2 and FeCl3. Org. Lett. 2012, 14, 4478–4481. [Google Scholar] [CrossRef] [PubMed]
  8. Okamura, Y.; Sato, D.; Yokomura, A.; Zhdankin, V.V.; Saito, A. Iodine(III)-mediated/catalyzed cycloisomerization-amination sequence of N-propargyl carboxamides. Adv. Synth. Catal. 2017, 359, 3243–3247. [Google Scholar] [CrossRef]
  9. Yu, X.; Xin, X.; Wan, B.; Li, X. Base-catalyzed cyclization of N-sulfonyl propargylamines to sulfonylmethyl-substituted oxazoles via sulfonyl migration. J. Org. Chem. 2013, 78, 4895–4904. [Google Scholar] [CrossRef] [PubMed]
  10. Milton, M.D.; Inada, Y.; Nishibayashi, Y.; Uemura, S. Ruthenium- and gold-catalyzed sequential reactions: A straightforward synthesis of substituted oxazoles from propargylic alcohols and amides. Chem. Commun. 2004, 23, 2712–2713. [Google Scholar] [CrossRef] [PubMed]
  11. Kumar, M.P.; Liu, R.-S. Zn(OTf)2-catalyzed cyclization of proparyl alcohols with anilines, phenols, and amides for synthesis of indoles, benzofurans, and oxazoles through different annulation mechanisms. J. Org. Chem. 2006, 71, 4951–4955. [Google Scholar] [CrossRef] [PubMed]
  12. Pan, Y.-M.; Zheng, F.-J.; Lin, H.-X.; Zhan, Z.-P. Bronsted acid-catalyzed propargylation/cycloisomerization tandem reaction: One-pot synthesis of substituted oxazoles from propargylic alcohols and amides. J. Org. Chem. 2009, 74, 3148–3151. [Google Scholar] [CrossRef] [PubMed]
  13. Morita, N.; Yasuda, A.; Shibata, M.; Ban, S.; Hashimoto, Y.; Okamoto, I.; Tamura, O. Gold(I)/(III)-catalyzed synthesis of cyclic ethers; valency-controlled cyclization modes. Org. Lett. 2015, 17, 2668–2671. [Google Scholar] [CrossRef] [PubMed]
  14. Morita, N.; Tsunokake, T.; Narikiyo, Y.; Harada, M.; Tachibana, T.; Saito, Y.; Ban, S.; Hashimoto, Y.; Okamoto, I.; Tamura, O. Gold(I)/(III)-catalyzed synthesis of 2-substituted piperidines; valency-controlled cyclization modes. Tetrahedron Lett. 2015, 56, 6269–6272. [Google Scholar] [CrossRef]
  15. Morita, N.; Saito, Y.; Muraji, A.; Ban, S.; Hashimoto, Y.; Okamoto, I.; Tamura, O. Gold-catalyzed synthesis of 2-substituted azepanes; strategic use of soft gold(I) and hard gold(III) catalysts. Synlett 2016, 27, 1936–1940. [Google Scholar] [CrossRef]
  16. Morita, N.; Miyamoto, M.; Yoda, A.; Yamamoto, M.; Ban, S.; Hashimoto, Y.; Tamura, O. Gold-catalyzed dehydrative Friedel-Crafts reaction and Nazarov cyclization sequence: An efficient synthesis of 1,3-diarylindenes from propargylic alcohols. Tetrahedron Lett. 2016, 57, 4460–4463. [Google Scholar] [CrossRef]
  17. Morita, N.; Oguro, K.; Takahashi, S.; Kawahara, M.; Ban, S.; Hashimoto, Y.; Tamura, O. Gold(III)-catalyzed synthesis of 2,3,4-trisubstituted dihydropyrans from propargylic alcohols with 1,3-dicarbonyl compounds. Heterocycles 2017, 95, 172–180. [Google Scholar]
  18. Morita, N.; Sano, A.; Sone, A.; Aonuma, S.; Matsunaga, A.; Hashimoto, Y.; Tamura, O. Efficient one-pot synthesis of substituted oxazoles from 3-trimethylsilylpropargylic alcohols and amides by gold-catalyzed substitution followed by cycloisomerization. Heterocycles 2018, 97, 719–728. [Google Scholar]
  19. Weyrauch, J.P.; Hashmi, A.S.K.; Schuster, A.; Hengst, T.; Schetter, S.; Littmann, A.; Rudolph, M.; Hamzic, M.; Visus, J.; Rominger, F.; et al. Cyclization of propargylic amides: Mild access to oxazole derivatives. Chem. Eur. J. 2010, 16, 956–963. [Google Scholar] [CrossRef] [PubMed]
  20. CCDC 2239857. Contains the Supplementary Crystallographic Data for This Paper. Available online: http://www.ccdc.cam.ac.uk/conts/retrieving.html (accessed on 4 February 2023).
Scheme 1. Synthesis of oxazoline and oxazole.
Scheme 1. Synthesis of oxazoline and oxazole.
Molbank 2023 m1600 sch001
Scheme 2. One-pot synthesis of substituted oxazoles via gold(III)-catalyzed propargylic substitution followed by cycloisomerization.
Scheme 2. One-pot synthesis of substituted oxazoles via gold(III)-catalyzed propargylic substitution followed by cycloisomerization.
Molbank 2023 m1600 sch002
Scheme 3. Strategic use of the valence of gold catalysts. Gold(III)-catalyzed propagylic substitution followed by gold(I)-catalyzed cyclization/cycloisomerization.
Scheme 3. Strategic use of the valence of gold catalysts. Gold(III)-catalyzed propagylic substitution followed by gold(I)-catalyzed cyclization/cycloisomerization.
Molbank 2023 m1600 sch003
Scheme 4. Gold(III)-catalyzed propargylic substitution followed by gold(I)-catalyzed cyclization.
Scheme 4. Gold(III)-catalyzed propargylic substitution followed by gold(I)-catalyzed cyclization.
Molbank 2023 m1600 sch004
Figure 1. (A) ORTEP diagram of (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole (15) with thermal ellipsoids at the 50% probability level. (B) Packing diagram of 15 along the b axis. Atom colors: (a) blue = nitrogen, (b) white = hydrogen, (c) red = oxygen, (d) grey = carbon. Interaction colors: (e) green line = π−π stacking interaction, and (f) yellow line = CH-π interaction.
Figure 1. (A) ORTEP diagram of (Z)-5-benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole (15) with thermal ellipsoids at the 50% probability level. (B) Packing diagram of 15 along the b axis. Atom colors: (a) blue = nitrogen, (b) white = hydrogen, (c) red = oxygen, (d) grey = carbon. Interaction colors: (e) green line = π−π stacking interaction, and (f) yellow line = CH-π interaction.
Molbank 2023 m1600 g001
Table 1. Summary of the crystallographic data and refinement statistics for 15.
Table 1. Summary of the crystallographic data and refinement statistics for 15.
ParameterData
Identification codeC23H19NO
Formula weight325.29
Temperature/K293(2)
Crystal systemtriclinic
Space groupP-1
Unit cell dimensionsa/Å 8.0541(4) α/o 81.010(4)
b/Å 9.3301 (5) β/o 89.182(4)
c/Å 11.8454(6) γ/o 72.271(5)
Volume/Å3836.91(8)
Z2
ρcalc g/cm31.291
μ/mm−10.611
F(000)344.0
Crystal size/mm-10.25 × 0.15 × 0.20
RadiationCu Kα (λ = 1.54184)
2Θ range for data collection/°16.83 to 102.658
Index ranges−8 ≤ h ≤ 8, −9 ≤ k ≤ 9, −5 ≤ l ≤ 11
Reflections collected1752
Independent reflections1462 [Rint = 0.0045, Rsigma = 0.0121]
Data/restraints/parameters1462/0/227
Goodness-of-fit on F21.056
Final R indexes [I ≥ 2σ (I)]R1 = 0.0301, wR2 = 0.0781
Final R indexes [all data]R1 = 0.0316, wR2 = 0.0793
Largest diff. peak/hole/e Å−30.17/−0.17
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Morita, N.; Chiaki, H.; Aonuma, S.; Tanaka, K., III; Hashimoto, Y.; Tamura, O. (Z)-5-Benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole. Molbank 2023, 2023, M1600. https://doi.org/10.3390/M1600

AMA Style

Morita N, Chiaki H, Aonuma S, Tanaka K III, Hashimoto Y, Tamura O. (Z)-5-Benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole. Molbank. 2023; 2023(1):M1600. https://doi.org/10.3390/M1600

Chicago/Turabian Style

Morita, Nobuyoshi, Hitomi Chiaki, Shino Aonuma, Kosaku Tanaka, III, Yoshimitsu Hashimoto, and Osamu Tamura. 2023. "(Z)-5-Benzylidene-4-phenyl-2-(p-tolyl)-4,5-dihydrooxazole" Molbank 2023, no. 1: M1600. https://doi.org/10.3390/M1600

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop